NCT05921890

To Evaluate the Safety and Tolerability of Multiple Doses of GS3-007a Oral Solution in Healthy Subjects.

To Evaluate the Safety and Tolerability of GS3-007a Oral Solution in a Multi-dose, Randomized, Open, Single-center Study in Healthy Chinese Adult Subjects.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To evaluate the safety and tolerability of GS3-007a oral solution after multiple oral administration in Chinese healthy adult subjects.

Detailed description

To evaluate the pharmacodynamic (PD) and pharmacokinetics（PK） characteristics of GS3-007a oral solution after multiple oral administration in Chinese healthy adult subjects

Conditions

• Healthy Subject

Interventions

Type	Name	Description
DRUG	GS3-007 oral liquid	The dosage was calculated according to body weight, once a day or twice a day.

Timeline

• Start date: 2023-06-19
• Primary completion: 2023-10-28
• Completion: 2023-10-28
• First posted: 2023-06-27
• Last updated: 2023-11-09

Locations

1 site across 1 country: China